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In reply,
With great curiosity we have read the letter to editor by 
Bongomin F. and colleagues1 written as a comment to 
our recent published article in African Health Sciences2, 
we appreciate their interest to our article and inputs. The 
interest of  the study was to investigate the risk factors for 
esophageal candidiasis (EC). The risk factors are clearly 
indicated in the original manuscript regardless of  HIV sta-
tus1. In addition, HIV was also analysed as one of  the risk 
factor as previously reported elsewhere 3,4. The increase 
in age was found to protect the patients from developing 
EC as previous published5. In order not to confuse the 
reader, the odd ratio and 95%confidence interval for age 
variable in table 2 in the original article1 was reversed to 
show the decrease in age as the risk of  ECand presented 
in the abstract and content of  the original manuscript1.
In addition, in this letter to editor we have included re-
sults regarding factors associated with EC in HIV nega-
tive individuals. Of  554 HIV negative patients, 20(3.6%) 
had EC. On multivariate logistic regression analysis, in-
crease in age independently protected HIV negative pop-
ulation from getting EC (OR 0.95, 95%CI; 0.92-0.99; 
p=0.0035), whilebeing female (OR 11.74, 95%CI; 1.55-
88.82; p=0.017), alcohol use(OR 20.45, 95%CI; 4.89-
86.56; <=0.001), smoking(OR 5.44, 95%CI; 1.18-25.12; 
p=0.03), antibiotic use(OR 5.2, 95%CI; 1.67-16.21; 
p<0.005), and having peptic ulcer diseases  (OR 8.24, 
95%CI; 2.21-30.72; p<0.002) independently predicted 
EC among HIV negative patients (table 4).  
Table 4: Risk factors associated with esophageal candidiasis among HIV negative 
patients attending endoscopy unit (n=554)   
PUD is the peptic ulcer diseases; some known variable like use of corticosteroid, having diabetic and asthma were 
not include in multivariate analysis because the patients with EC were very few which could lead to a very wide 
confidence interval. 
Variable  Univariate  Multivariate 
   





Age* 3931-50 0.99(0.96-1.02) 0.365 0.95(0.92-0.99) 0.035 
Sex       
Male (307) 11(3.6) 1    
Female (247) 9(3.6) 1.02(0.414-2.496) 0.97 11.74(1.55-88.82) 0.017 
Alcohol       
No (475) 6(1.3) 1    
Yes (79) 14(17.7) 16.8(6.25-45.35) <0.001 20.45(4.89-86.56) <0.001 
Smoking      
No (515) 13(2.5) 1    
Yes (39) 7(18) 8.45(3.15-22.64) <0.001 5.44(1.18-25.12) 0.03 
Corticosteroid 
use 
     
No (551) 18(3.3) 1    
Yes (3) 2(66.7) 59.2(5.13-683.5) 0.001 - - 
Clinical 
presentation 
     
No (241) 3(1.2) 1    
Yes (313) 17(5.43) 4.56(1.32-15.73) 0.016 3.90(0.90-16.85) 0.068 
Antibiotics use       
No (448) 9(2.01) 1    
Yes (106) 11(10.38) 5.64(2.27-14.01) <0.001 5.2(1.67-16.21) 0.005 
Diabetic       
Negative (542) 14(2.6) 1    
Positive (12) 6(50.0) 37.7(10.81-
131.62) 
<0.001 - - 
PUD      
No (473) 13(2.8) 1    
Yes (81) 7(8.6) 3.35(1.29-8.66) 0.013 8.24(2.21-30.72) 0.002 
Asthma       
No (550) 18(3.27) 1    
Yes (4) 2(50.0) 29.56(3.94-
221.79) 
0.001 - - 
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Furthermore, we have noted that, the original published 
article did not incorporate the corrections which were 
presented during proofreading, for this reason we have 
presented the correct table 3 as seen below:
Table 3: Characteristics of HIV negative patients with EC 
S/number Sex Age Presentation Alcohol Smoking Antibiotic Diabetic Cirrhosis PUD Asthma 
1 Male 20 Hemoptysis Yes Yes No No Yes No No 
2 Female 24 Ep. pain No No Yes No No Yes No 
3 Male 32 Ep. Pain Yes Yes Yes No No No No 
4 Female 30 Ep. Pain Yes No Yes No No No No 
5 Male 47 Dysphagia Yes Yes Yes Yes No No No 
6 Female 17 Dysphagia No No No No No No Yes 
7 Male 40 Ep. pain Yes No Yes No No Yes No 
8 Female 38 Ep. pain Yes No No Yes No No No 
9 Female 47 Ep. pain No No No Yes No No No 
10 Male 77 Ep. pain Yes Yes Yes No No No No 
11 Female 38 Ep. pain No No Yes No No Yes No 
12 Male 34 UGIB Yes Yes No No No Yes No 
13 Female 60 Ep. pain Yes No Yes No No Yes No 
14 Male 28 Ep. pain Yes Yes No No No No No 
15 Male 40 Dysphagia Yes No No Yes No Yes No 
16 Male 36 Ep. pain Yes No Yes Yes No No No 
17 Male 44 UGIB Yes Yes No No Yes No No 
18 Female 62 Ep. pain No No No Yes No No No 
19 Female 33 Ep. pain Yes No Yes No No Yes No 
20 Male 23 Ep. pain No No Yes No No No Yes 
Note; Ep. Pain is epigastric pain and UGIB is upper gastro intestinal bleeding 
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